GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Capex-to-Operating-Cash-Flow

RP Bio lnc (XKRX:314140) Capex-to-Operating-Cash-Flow : 0.30 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

RP Bio lnc's Capital Expenditure for the three months ended in Mar. 2024 was ₩-514.32 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was ₩1,726.37 Mil.

Hence, RP Bio lnc's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2024 was 0.30.


RP Bio lnc Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for RP Bio lnc's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Capex-to-Operating-Cash-Flow Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Capex-to-Operating-Cash-Flow
5.47 1.81 0.77 4.57

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 2.81 0.53 0.64 0.30

Competitive Comparison of RP Bio lnc's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RP Bio lnc's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's Capex-to-Operating-Cash-Flow falls into.



RP Bio lnc Capex-to-Operating-Cash-Flow Calculation

RP Bio lnc's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-5279.11) / 1154.988
=4.57

RP Bio lnc's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-514.318) / 1726.374
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RP Bio lnc  (XKRX:314140) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


RP Bio lnc Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc (XKRX:314140) Business Description

Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc (XKRX:314140) Headlines

No Headlines